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Abstract 
The transport protein particle (TRAPP) is a hetero-multimeric complex involved in the trafficking of 
COP II (coat protein complex-II) vesicles. TRAPP is present in different eukaryotes from yeast to verte-
brates and occurs in three distinct modifications with function in different intracellular transport 
steps. All forms contain a core of five essential subunits, and the different species of TRAPP are 
formed by the addition of various subunits. A recently identified TRAPP-associated protein, Tca17, is 
supposed to be involved in the regulation of the transport complex. We have determined the three-
dimensional structure of yeast Tca17 by X-ray crystallography at a resolution of 1.8 Å. It adopts the 
longin fold characteristic for the Bet5 family of TRAPP subunits, and it also shares a binding motif of 
these for the interaction with other members of the complex. Two alternative models of the localiza-
tion of Tca17 within TRAPP as well as its potential role in the regulation of TRAPP function by 
transient integration into the complex are discussed. 
Database: Structural data are available in the Protein Databank (PDB) under the accession number 
3PR6. 
 
Introduction 
Cargo transport across and between the membranes of eukaryotic cells relies on vesicles, small 
containers enclosed in membrane bilayers that facilitate transport following anterograde (secretory) 
and retrograde pathways. The molecular machinery that carries out central functions in vesicular 
transport is functionally conserved across all eukaryotic species and between individual transport 
steps [1]. Vesicular transport between a cellular donor and an acceptor compartment follows a series 
of distinct steps starting with cargo recruitment at the donor membrane, followed by vesicle 
budding, release and uncoating, and ending with vesicle tethering at the acceptor membrane, SNARE 
protein pairing, membrane fusion and cargo release [2]. Each transport event encompassing these 
steps is thought to be carried out by a functional module of the cell [3]. 
Upon vesicle tethering, first physical contact is established between the transport container and the 
target membrane. Tethering depends on three classes of proteinaceous factors: A small GTPase of 
the Rab/Ypt family that travels with the vesicle, one or more proteins with extended coiled-coil 
regions anchored at the target membrane, or a multi-subunit tethering complex recruited to the 
target membrane and composed of soluble components [4-6]. Secretory COP II vesicles formed at 
the endoplasmic reticulum are tethered to the cis-Golgi membrane by the GTPase Rab1 (Ypt1 in 
yeast), the golgin p115 (Uso1 in yeast) and the transport protein particle (TRAPP). 
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TRAPP is a large multisubunit complex of which three forms have been identified in yeast, each 
having a unique composition and showing a particular function in the vesicular transport pathway 
[7]. In mammals, the number and composition of TRAPP complexes is less clear, but orthologous 
subunits have been identified, and there is evidence for distinct TRAPP complexes to be involved in 
the regulation of mammalian ER-to-Golgi traffic [8]. TRAPP I contains at least five subunits (mammal-
ian nomenclature in parentheses), Bet3-A, Bet3-B (TRAPPC3, 3L), Bet5 (TRAPPC1), Trs23 (TRAPPC4), 
and Trs31 (TRAPPC5). TRAPP I acts as a GTP exchange factor (GEF), and it recognizes and binds ER-
derived COP II vesicles to the Golgi apparatus [9-11]. Two subunits, Trs20 (TRAPPC2, Sedlin) and 
Trs33 (TRAPPC6, 6a, 6b) are required for the assembly of the TRAPP-II complex which, in addition to 
the TRAPP-I core, contains three proteins, the non-essential Trs65 (TRAPPC13), Trs120 (TRAPPC9), 
and Trs130 (TRAPPC10) [12]. The latter two shift the tethering specificity of the mammalian TRAPP 
complex from COP-II to COP-I coated vesicles, presumably through direct interaction with γ1COP, a 
COP-I coat adaptor protein [13]. Structural studies by X-ray crystallography of various TRAPP sub-
complexes from mammals [14] and yeast [15] have led to the following composite picture of yeast 
TRAPP I architecture: 
The complex forms an elongated structure of ca. 180 Å length, resting flat on the cytosolic side of the 
Golgi membrane. Two hetero-trimeric sub-complexes consist of Bet3-A, Trs33  and Bet5 on the one 
side, and of Bet3-B, Trs31 and Trs23 on the other side. The interface between the two halves of the 
TRAPP I complex is formed by Bet5 and Trs23, which are related by a pseudo two-fold symmetry axis 
oriented perpendicular to the membrane. An additional subunit, Trs20 (Sedlin in mammals), binds to 
Trs31. The complex is thought to associate with the membrane via Bet3-A/B, since no other anchor-
ing protein could be identified so far [16, 17]. Very little is known about the quaternary structure of 
TRAPP II. A recent EM study of the complex from yeast containing all subunits shows a diamond-
shaped structure formed by the dimerization of two nine-component core complexes [18]. However, 
the exact arrangement of the components of TRAPP II is unresolved with at least four models under 
discussion [19]. 
A third complex, TRAPP III, has been identified as acting in autophagy, and it contains the TRAPP I 
components and additionally the TRAPP-III specific subunit Trs85 (TRAPPC8) [20, 21]. Structure 
analysis by EM has shown that TRAPP III is formed by the attachment of Trs85 to the Trs20-binding 
end of the elongated TRAPP-I structure [22]. 
Recently, an additional member, Tca17, of the yeast TRAPP complex was identified. Tca17 is 
proposed to be a component of TRAPP II and to promote the assembly and stability of the complex 
through interaction with Trs33 and Trs130 [21, 23]. A similar result was reported for its human 
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ortholog, TRAPPC2L [24]. Based on sequence similarity, TRAPPC2L is remotely related to the TRAPP 
subunit Sedlin which is grouped in the same family of small TRAPP subunits as Bet5 and Trs23 [6]. 
Here we have determined by X-ray crystallography the three-dimensional structure of Tca17 from 
yeast at a resolution of 1.80 Å. It shows that Tca17 indeed adopts the longin fold characteristic for 
the Bet5 subfamily of TRAPP subunits. It is most closely related to Trs20/Sedlin, and its surface 
properties suggest that it can bind to other TRAPP subunits. Its role in the regulation of TRAPP 
function by transient integration into the complex is discussed.  
 
Results and Discussion 
Crystal structure analysis of Tca17 from yeast 
The coding region for full-length Tca17 (residues 1-152) from yeast was heterologously expressed in 
E. coli and purified utilizing an N-terminal GST-affinity tag, followed by removal of the tag and size 
exclusion chromatography. The crystal structure of Tca17 was determined by multi-wavelength 
anomalous diffraction (MAD) at a resolution of 1.80 Å. Tca17 crystallizes in space group C2 with one 
molecule per asymmetric unit. 141 out of 152 amino acid residues of Tca17 could be traced in the 
electron density, while two residues at the N-terminus as well as the loop connecting strand β2 and 
helix α1 (Fig. 1) could not be modeled, probably due to local disorder. At the C-terminus of the 
protein, two additional amino acids derived from the cloning vector could be fitted into the electron 
density.  
As a member of the Bet5 subfamily of TRAPP complex subunits, Tca17 shows a longin-like fold, where 
a central β-sheet formed by five anti-parallel β-strands is flanked by one α-helix (α1) on one side 
(“one-helix side”, Fig. 1A) and two α-helices (α2, α3) on the opposite side (“two-helix side”, Fig. 1B). 
In contrast to other Bet5-like proteins, the C-terminus of Tca17 extends beyond helix α3 and forms 
an additional short helix α4, which points away from the rest of the protein, but it is stabilized by 
crystal contacts with a symmetry-related molecule. Besides two hydrogen bonds, the interface 
involves mostly hydrophobic interactions between several leucine and valine side-chains. This 
interface includes, however, non-native residues derived from the cloning process of the protein and 
is therefore unlikely to be physiologically relevant. Another interface is formed with a second 
molecule related by the two-fold rotation axis. Here, the Cys121 side-chains of the two molecules are 
covalently linked by a disulfide bond. We assessed therefore the oligomerization state of Tca17 in 
solution by a number of orthogonal assays such as sedimentation velocity experiments through 
analytical ultracentrifugation, analytical size exclusion chromatography combined with static light 
scattering (SLS), and SDS-PAGE, all under reducing and non-reducing conditions. Even in the absence 
of a reducing agent, more than 95% of Tca17 was observed to exist in the monomeric form in all 
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experiments (data not shown). Finally, analysis of the interface between the two monomers [25] 
renders a Tca17 dimer in the absence of a disulfide bond under physiological conditions in the 
cytosol rather unlikely.  
Comparison of Tca17 with members of the TRAPP complex 
The protein pair of Tca17 (TRAPPC2L in mammals) and Trs20 (TRAPPC2/Sedlin in mammals) is found 
in a variety of eukaryotic species, suggesting a distinct and conserved function for either protein. 
Recent studies have shown that Trs20 is required for assembly of the TRAPP II complex and that it is 
essential for the viability of yeast cells [19]. It is also essential for TRAPP III formation, and mutation 
of Trs20 leads to defects in TRAPP III-dependent autophagy [26]. A similar role as an adaptor for 
TRAPP assembly was shown for the mammalian ortholog TRAPPC2 [27, 28]. To understand the 
function of Tca17 on the basis of sequence conservation, Tca17 orthologs from eighteen different 
species, including the well characterized orthologs from metazoans as well as several hypothetical 
proteins from yeasts, were aligned using Clustal Omega [29]. Sequence conservation was 
subsequently analyzed using ConSurf [30]. The normalized ConSurf score for each residue in the 
multiple sequence alignment (Fig. 2) is a relative measure of evolutionary conservation, with the 
lowest score representing the most conserved position in a given protein family. The structure of 
Tca17 colored according to sequence conservation is shown in Fig. 3A. In general, Tca17/TRAPPC2L is 
less conserved thanTrs20/TRAPPC2 [24], as expected for a protein which is not involved directly in 
the function of the TRAPP complex, but rather serves in a regulatory role. The majority of the most 
conserved residues are found in the hydrophobic core of the lower part of Tca17 (Fig. 3A).  Distribu-
tion of main-chain atomic displacement factors also suggests low internal flexibility in this part of the 
protein. Taken together, maintaining a stable fold in this region seems to be important for the 
function of Tca17. In addition, two distinct conserved patches can be identified on opposite surfaces 
of Tca17 (Fig. 3B). 
As a member of the Bet5 subfamily of TRAPP subunits, Tca17 shares a longin-like fold with Sedlin, 
Bet5, and Trs23. This raises the possibility that Tca17 is integrated into the TRAPP complex in place of 
any of these three TRAPP subunits. Since a regulatory function of Tca17 is expected to result from 
protein-protein interactions, the electrostatic potential distributions of the four Bet5 subfamily 
members were computed for comparison, and they are shown in Fig. 4 with the proteins in the same 
orientations of their longin-like core structures. For Tca17 the picture is qualitatively similar to that of 
Sedlin, but clearly different from Bet5 and Trs23, particularly on the one-helix side. Here, Tca17 as 
well as Sedlin show a widely spread area of negative charge, with a concentrated patch that is for 
Sedlin located on the presumably cytosolic side of the TRAPP complex, and therefore open for 
protein-protein interactions, e.g. with SNARE proteins such as Syntaxin 5 [14, 28, 31]. This area is 
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highly conserved among Tca17/TRAPPC2L proteins from various species (patch 1 in Fig. 3B) as well as 
in comparison with the TRAPPC2 protein family, suggesting an important interaction site [23, 24]. 
Indeed, Trs20 facilitates the assembly of both TRAPP II and III through interaction with Trs120 and 
Trs85, respectively, and the mutation Asp46Tyr abolishes this [19, 26-28]. Mutation of the equivalent 
residue (Asp47) in human Sedlin is one of the causes leading to the X-linked skeletal disorder 
spondyloepiphyseal dysplasia tarda (SEDT) [32, 33], which underlines the importance of this region 
for the functionality of the TRAPPC2/C2L family. When the structures of Tca17 (Leu44-Asp45) and 
Sedlin (Leu46-Asp47) are superimposed, these residues are located at similar positions on the 
protein surface, and the orientation of their side-chains is similar (Fig. 5), suggesting that this spot 
serves as a specific protein binding site. Looking from the two-helix side, Tca17 and Sedlin appear 
less similar (Fig. 4). While the surface of Sedlin is mostly neutral, with only a few spots of positive 
charge, Tca17 shows a distinct negative patch, composed of the β2-α2 loop and the beginning of 
helix α2. 
Localization of Tca17 in the TRAPP II complex 
Cell-biological studies have raised two possibilities for the integration of Tca17 into yeast TRAPP 
complexes (Fig. 6). First, Tca17 could be co-purified with a Bet3-Trs31 hetero-dimer [24], indicating a 
presumably transient replacement of Trs20 in TRAPP. After docking of the coordinates of Tca17 into 
the present model of TRAPP I [14] in the same orientation as it is found for Sedlin (Tca17-A, Fig. 6A), 
it is evident that, if Tca17 is indeed integrated into TRAPP in place of Sedlin/Trs20, a strong negatively 
charged area is created on the surface of TRAPP facing the membrane and presumably weakening 
the association with it (Fig. 6B). We notice, however, that this region of Tca17/TRAPPCL2 is only 
weakly conserved (Fig. 2), implying a non-essential function. The negative patch also extends further 
to the side of the protein which is facing away from the TRAPP I core (Fig. 6C). This end of TRAPP 
would be capped by the TRAPP II-specific subunit Trs130 in the EM-derived yeast TRAPP II model 
[18]. The co-localization of Tca17 and Trs130 has been shown [23, 28], and it seems possible that this 
patch on the surface of Tca17 links it with the TRAPP II complex. 
In a second scenario for its interaction with TRAPP, Tca17 binds in a position between Bet3 and Trs33 
at the opposite end of the complex which is related by a pseudo two-fold symmetry to the binding 
site of Sedlin (Tca17-B, Fig. 6A) [21]. This is corroborated by co-precipitation experiments that have 
shown the interaction of Tca17 with Trs33 in yeast [23] as well as of the human orthologs TRAPPC2L 
and TRAPPC6a [24]. In the latter study, co-IP experiments also suggest that TRAPPC2 and TRAPPC2L 
both reside in the same TRAPP complex rather than replace each other. Docking of our Tca17 
coordinates into the TRAPP I model in this position creates a similar negatively charged patch on the 
putative membrane-facing side of the complex as the replacement model with Trs20 does (Fig. 6B,C). 
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While in the EM-derived TRAPP II model [18], this end of the complex is capped by Trs120, an 
alternative model following two-hybrid analysis and co-purification/-immunoprecipitation experi-
ments suggests the direct interaction of Tca17 with the N-terminal region of Trs130 at his position 
[21, 28]. Finally, Tca17 has not been detected yet in the TRAPP III complex, and in a tca17Δ yeast 
strain neither assembly nor function of the complex are affected [22, 26, 28].  Therefore, Tca17 does 
not seem to be an essential subunit of TRAPP III or, indeed, to interact with Trs85 in exchange of 
Trs20. 
The crystal structure of Tca17 allows us to predict and analyze possible interactions with TRAPP I-
core subunits such as Bet3, Trs31 or Trs33 on a molecular level. The predicted Bet3-interaction site of 
yeast Tca17 in comparison to the same site of mammalian Sedlin is shown in Fig. 7A. The interaction 
motif is relatively conserved (Sedlin: 111MNPF, Fig. 7B, Tca17: 121CNPL, Fig. 7C), corresponding to 
patch 2 in Fig. 3B. Being located between helix α2 and helix α3, it is accessible to protein binding by 
protruding from the structure of Tca17. In the crystal structure of Tca17, Cys121 is involved in 
disulfide bond formation. However, as discussed above, this is likely to be a crystallization artifact, 
and under reducing conditions in the cytosol this residue is expected to be accessible for interactions. 
While the binding modes between Tca17 and either Bet3-A or Bet3-B in the two alternative models 
described above are expected to be very similar, the interactions of Tca17 with Trs31 and Trs33 must 
be different. Fig. 8 shows the interfaces of the putative binding partners together with the surface 
patch of Sedlin that faces Trs31 in the TRAPP I model (see Fig. 6A). The charge distribution on the 
solvent-accessible surfaces of Trs31 and Trs33 are clearly different, with a unique negative area on 
the latter that might be matched by a corresponding positive patch on Tca17. However, this does not 
allow to decide for or against one of the proposed models. Also, no sequence conservation between 
Sedlin and Tca17 can be found here, while the interface of Sedlin and Trs31 is maintained through a 
number of hydrogen bonds (data not shown). In absence of a complex structure, it is not possible to 
find conclusive evidence on a molecular level for the interaction of Tca17 and Trs31 or Trs33. 
 
Conclusion 
We have determined the three-dimensional structure of the formerly little known yeast TRAPP-
associated protein, Tca17. Though not previously identified as a TRAPP subunit, Tca17 as well as its 
mammalian ortholog TRAPPC2L were described to be sub-stoichiometric components of TRAPP II and 
to promote the assembly and stability of the complex. The crystal structure analysis at 1.8 Å resolu-
tion shows that Tca17 adopts the longin fold characteristic for the Bet5 subfamily of small TRAPP 
subunits. On the sequence and structure level, Tca17 is most closely related to the TRAPP subunit 
Trs20p/Sedlin. In addition, Tca17 shares a characteristic sequence motif with Trs20/Sedlin for the 
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interaction with Bet3. Transient integration of Tca17 into TRAPP, either replacing Trs20 or as an 
additional subunit would create a negatively charged patch on the suggested membrane association 
interface of the complex which might explain the role of Tca17 in the regulation of TRAPP-mediated 
vesicle tethering. On the other hand, residues found to be essential in Trs20/Sedlin for protein-
protein interactions that lead to the assembly of TRAPP II and TRAPP III complexes are strictly 
conserved on the sequence as well as the structure level suggesting a related function for Tca17. In 
accordance with a number of recent cell-biological studies, our analysis of the structure of Tca17 
points towards a role as an adaptor protein in TRAPP II assembly possibly by interacting with Trs130 
and complementary to the interaction of Trs20 and Trs120. Further experiments, including the 
molecular and structural analysis of sub-complexes, are needed to validate the proposed interactions 
of Tca17 with members of the TRAPP complex. 
 
Material and Methods 
Expression cloning and protein purification of Tca17 
The coding region for full-length Tca17 (residues 1-152) was amplified directly from yeast genomic 
DNA and cloned into the bacterial expression vector pGEX-6P1 using BamHI/NotI restriction endo-
nucleases. After transformation of E. coli BL21 (DE3)-T1R cells with the recombinant plasmid pGEX6-
P1-Tca17, large-scale gene expression was induced by addition of 0.1 mM isopropyl-1-thio-β-D-
galactopyranoside (IPTG) to LB medium, and cells were harvested after growing at 20 °C overnight. 
Seleno-methionine (SeMet)-labeled Tca17 was produced according to the protocol in [34]. Briefly, a 
preculture of E. coli BL21 (DE3)-T1R cells (transformed with GEX6-P1-Tca17) in LB medium was used 
to inoculate M9 medium supplemented with ampicillin, thiamine and FeSO4. After reaching an OD600 
of 0.5, amino-acid synthesis was suppressed by addition of solid amino acids, gene expression was 
induced by addition of 1 mM IPTG, and cells were grown at 20 °C overnight. 
Cell lysate containing Tca17 fused to a glutathione-S-transferase affinity tag at its N-terminus was 
applied to glutathione Sepharose 4B (GE Healthcare) and, after a wash step with PBS (9.55 g/l 
Instamed PBS Dulbecco), eluted with 20 mM reduced glutathione (100 mM Tris, pH 8.0). For removal 
of the GST tag, pooled fractions containing GST-Tca17 were mixed with PreScission™ protease (GE 
Healthcare) at a ratio of 30:1, and they were dialyzed against 50 mM Tris, 150 mM NaCl and 5 mM 2-
mercaptoethanol, pH 8.0 at 4 °C overnight. After loading of the digestion mixture onto a second 
glutathione Sepharose 4B chromatography column, the flow-through was collected, concentrated 
and applied to a Superdex® 75 Hiload size exclusion chromatography column that had been equili-
brated with 20 mM HEPES, 300 mM NaCl, 2 mM DTT, and 5% v/v glycerol, pH 7.0. For purification of 
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SeMet-substituted Tca17, the buffer also contained 1 mM EDTA. Fractions containing Tca17 were 
pooled and concentrated to 12 mg · ml-1 for subsequent experiments.  
Crystallization and data collection 
Diffraction-quality crystals of full-length Tca17 were grown by the sitting-drop vapor diffusion techni-
que in 100 mM Tris, 200 mM MgCl2, 15% w/v PEG 3350, pH 8.5 at 4 °C after 2 months. Single crystals 
were harvested by brief incubation in reservoir buffer including 15% v/v glycerol as cryo-protectant 
and flash-freezing in liquid nitrogen. Since the Se-Met-labeled crystals of Tca17 diffracted better than 
the crystals of the native protein, all data sets were collected from the former. Anomalous data 
(peak, inflection point, high-energy remote) were collected at beamline BL 14.1 of Berliner Elektro-
nensynchrotron (BESSY II, Helmholtz-Zentrum Berlin für Materialien und Energie), while the high-
resolution native data set was collected at BL 14.2 of BESSY II. All data were processed using XDS 
[35]. Data collection statistics are summarized in Table 1. 
Structure analysis 
MAD data sets were uploaded to and processed with the automatic crystal structure determination 
pipeline Auto-Rickshaw at EMBL-Hamburg [36]. The resulting electron density map and an initial 
protein model were used for manual modification and refitting with Coot [37] followed by refine-
ment with Refmac5 [38]. The refined co-ordinates were then used to determine the phases by 
molecular replacement (MR) of the high-resolution native data set at 1.8 Å. Subsequently, several 
rounds of manual modification (Coot) and refinement (Refmac5) led to the final model of Tca17 
(Table 1). Procheck [39] and MolProbity [40] were used for validation of the deposited model. 
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Tables 
 
Table 1. Crystallographic data collection and model refinement statistics 
aData for the highest resolution shell in parenthesis, bCalculated with BAVERAGE [41], cCalculated with 
MOLPROBITY [40], dClashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms. 
 
Data Collection 
Data sets Peak Inflection point Remote Native 
Wavelength [Å] 0.9797 0.9798 0.9720 0.9184 
Temperature [K] 100 
Space group C2 
Unit cell parameters 
a, b, c [Å] 
β [°] 
 
57.24, 46.75, 50.48 
92.92 
                                                   
57.13, 58.49, 53.97 
92.62 
Resolution range [Å]a 28.96-3.12 
(3.20-3.12) 
29.93-2.99 
(3.07-2.99) 
29.09-3.11 
(3.19-3.11) 
29.25-1.80 
(1.85-1.80) 
Reflectionsa 
Unique 
Completeness [%] 
Multiplicity 
 
4558 (323) 
98.1 (99.1) 
1.7 
 
5235 (396) 
98.1 (95.4) 
1.7 
 
4659 (342) 
97.9 (100.0) 
1.7 
 
16453 (1216) 
99.4 (99.5) 
3.2 
Data qualitya 
Intensity <I/σ(I)> 
Rmeas[%] 
Wilson B value [Å2] 
 
11.3 (2.3) 
6.4 (48.4) 
58.9 
 
11.8 (1.6) 
5.8 (65.2) 
65.6 
 
11.4 (1.9) 
6.4 (51.0) 
66.5 
 
17.5 (3.0) 
4.7 (47.4) 
35.31 
Refinement 
Resolution range [Å]a 29.25-1.80 (1.85-1.80) 
Reflectionsa 
Number 
Completeness [%] 
Test set (5%) 
 
15631 (1127) 
99.3 (97.8) 
823(59) 
Rwork 18.32 (20.30) 
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Rfree 21.96 (24.70) 
Contents of the 
asymmetric unit 
Protein: Molecules, 
residues, atoms 
Ligands: Molecules, 
atoms 
Water: Molecules 
 
 
 
1, 143, 1164 
 
 
2, 7 
133 
Mean displacement 
factors [Å2]b 
All atoms 
Protein 
Ligands 
Water oxygens 
 
 
31.76 
31.89 
65.66 
28.80 
RMSD from target 
geometry 
Bond lengths [Å] 
Bond angles [°] 
RMSD displacement 
factors [Å2]b 
Main chain 
Side chain 
 
 
0.011 
1.277 
 
 
0.731 
2.186 
Estimated mean 
coordinate error [Å] 
Based on Rfree 
Based on maximum 
likelihood 
 
 
0.025 
 
0.069 
Validation statisticsc 
Ramachandran map 
Residues in favored 
regions [%, No.] 
MOLPROBITY 
Clashscored 
 
 
 
100.0, 143 
 
4.1 
  
 Crystal structure of TRAPP-associated yeast Tca17  
 [16] 
Figure Legends 
 
Fig. 1. Cartoon representation of full-length Tca17, colored in a rainbow scheme from the N-terminus 
(dark blue) to the C-terminus (red). (A) As seen from the one-helix side, (B) after rotation of 180°, the 
molecule is shown from the two-helix side. Secondary structure elements (α-helices and β-strands) 
are labeled. Dashed sections of the chain could not be modeled due to local disorder. 
 
Fig. 2. ConSurf color-coded multiple sequence alignment [30] of Tca17/TRAPPC2L orthologs. Amino 
acid sequences are shown in the one-letter code. The degree of conservation is shown from variable 
(1, dark cyan) to conserved (9, dark magenta). Yellow letters indicate an insufficient number of 
residues that can be aligned (less than 10%). Regions that form continuous patches on the surface of 
Tca17 (see Fig. 3B) are marked as red boxes.  
The following Tca17 orthologs were included in the alignment (UniProt ID): Q753D1_ASHGO: Hypo-
thetical protein from Ashbya gossypii, Q6CJQ8_KLULA: Hypothetical protein from Kluyveromyces 
lactis, C5DXJ3_ZYGRC: Hypothetical protein from Zygosaccharomyces rouxii, TPC2L_BOVIN: 
TRAPPC2L from Bos taurus, C4XWA9_CLAL4: Hypothetical protein from Clavispora lusitaniae, 
TPC2L_SALSA: TRAPPC2L from Salmo salar, Q6FLS1_CANGA: Tca17-like protein from Candida 
glabrata, C4R7P1_PICPG: Hypothetical protein from Pichia pastoris, TPC2L_DICDI: TRAPPC2L from 
Dictyostelium discoideum, TPC2L_HUMAN: TRAPPC2L from Homo sapiens, TPC2L_MOUSE: TRAPPC2L 
from Mus musculus, A7TN14_VANPO: Hypothetical protein from Vanderwaltozyma polyspora, 
TPC2L_RAT: TRAPPC2L from Rattus norvegicus, TPC2L_TAEGU: TRAPPC2L from Taeniopygia guttata, 
TCA17_YEAST: Tca17 from Saccharomyces cerevisiae, C5DDR2_LACTC: Hypothetical protein from 
Lachancea thermotolerans, TPC2L_PONAB: TRAPPC2L from Pongo abelii, TPC2L_XENTR: TRAPPC2L 
from Xenopus tropicalis. 
  
Fig. 3. Sequence conservation of Tca17. Eighteen Tca17/TRAPPC2L ortholog proteins were aligned, 
and the sequence conservation was calculated by ConSurf [30]. (A) Ribbon representation of Tca17 
seen from the one-helix (left) and the two-helix (right) side. The coloring scheme corresponds to 
ConSurf scores ranging from variable (dark cyan) to conserved (dark magenta). Regions that are 
insufficiently represented within the set of orthologs are colored yellow. (B) Surface representation 
of Tca17. Orientations and coloring scheme as in (A). Two distinct, highly conserved patches are 
marked by dashed lines. 
 
Fig. 4. Electrostatic surface potential across the Bet5 protein family. Shown are Tca17 (PDB ID: 3PR6, 
this study), Bet5 (PDB ID: 3CUE, chain C), Sedlin (PDB ID: 2J3W, chain A) and Trs23 (PDB ID: 3CUE, 
chain A). All proteins are shown from the one-helix side (upper panel) and the two-helix side (lower 
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panel). The potential was calculated using APBS [42] and mapped onto the solvent-accessible surface 
by Pymol [43] between +3.0 kT/e (blue) and -3.0 kT/e (red). 
 
Fig. 5. Conserved patch 1 (see Figs. 2, 3) in Sedlin and Tca17. Superposition of Sedlin (cyan) and Tca17 
(magenta) shown from the one-helix side. The two conserved residues L44 and D45 of Tca17 
(L46/D47 in Sedlin) are shown as sticks. (Insert) Detail of patch 1.  
 
Fig. 6. Putative Integration of Tca17 into TRAPP. (A) Composite model for the TRAPP I complex from 
yeast. The complex was modeled by combining structural information from the mammalian Bet3-
Trs31-Sedlin complex [14], the mammalian Bet3-Tpc6A-Bet5-Trs23 complex [14], and the minimal 
sub-complex of yeast TRAPP I required for Ypt1 GEF activity [15]. Yeast TRAPP I model as seen from 
the putative membrane facing side. Two possible positions are shown for Tca17 (red), with Tca17-A 
replacing Sedlin (Trs20 in yeast) and Tca17-B being an additional subunit. In the mammalian complex 
structures, Sedlin (white ribbon representation) binds to Bet3 (yellow) and Trs31 (orange). The 
suggested positions of Tca17 in the yeast complex were found through superposition by secondary-
structure-matching in Coot [37]. 
(B) Replacement of Sedlin (Trs20 in yeast) by Tca17 changes the electrostatic surface potential of 
TRAPP. The TRAPP I model shown in (A) was used for calculation of the potential with APBS and 
Pymol (see Fig. 4) between +3.0 kT/e (blue) and -3.0 kT/e (red). TRAPP I model containing Sedlin 
(dashed box), membrane-facing side. (C) TRAPP I model with Tca17 (dashed boxes) added to the 
complex (Tca17-B) or docked into the position occupied by Sedlin (Tca17-A). Shown are the 
membrane-facing side (top) as well as a side view (bottom). 
 
Fig. 7. The Bet3-interacting motifs of Sedlin and Tca17. (A) The interface of Sedlin and Bet3 [14]. 
Surface representation of Bet3 (orange) with residues within 4.5 Å distance from Sedlin in blue. 
Sedlin is shown in yellow with residues involved in Bet3 interaction as stick models. (B) The Bet3 
interaction motif of Sedlin. (C) Putative Bet3-interaction motif of Tca17. 
 
Fig. 8. Electrostatic surface potential across the putative interfaces of Tca17-binding subunits of 
TRAPP. Shown are Trs33 (PDB ID: 2J3T, chain B), Tca17 (PDB ID: 3PR6, this study,), and Trs31 (PDB 
ID: 2J3W, chain B). Sedlin (PDB ID: 2J3W) is shown for comparison. The potential was calculated 
using APBS and Pymol (see Fig. 4) between +3.0 kT/e (blue) and -3.0 kT/e (red). Individual interfaces 
are outlined in black. 
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